Reduced kidney function from chronic kidney disease may undermine the accuracy of blood-based biomarkers used to predict AD outcomes.

Alzheimer’s disease doesn’t arrive suddenly. Instead, it emerges slowly, beginning with subtle changes that might be dismissed as normal aging before progressing through increasingly serious stages of ...

Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the ...

Alzheimer's Research UK has released figures suggesting that as many as one in three young people living in the UK today could develop dementia during their lifetime. However, Dr Sten Ekberg, a health ...

LEXINGTON, Ky. (WDKY) — University of Kentucky researchers who are involved in a clinical trial on the use of medical cannabis for late-stage dementia patients say the results could be a game changer, ...

An Australian-first trial involving brainwave stimulation has the potential to slow or reverse the early stages of dementia, ...

Hospice care aims to bring comfort, peace, and dignity to patients at the end of life. Yet for the growing number of ...